EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Changes in Symptoms and Cognition Following Electroconvulsive Therapy in Late-Life Depression: Analyses Stratified by Baseline Anxiety Levels

Veränderungen von Symptomen und Kognition nach Elektrokrampftherapie bei Depression im höheren Lebensalter: nach Ausgangsangst stratifizierte Analysen

Wenfeng Zhen, Han Wu, Shuo Lin, Dandi Zhu, Siyuan Lian, Li Ren, Yilang Tang, Yanping Ren iD, Xin Ma iD

Alpha Psychiatry · 09.09.2026 · 27 (5)

DOI: 10.31083/ap51154 ↗

Auf einen Blick

Bei 93 Patient:innen mit Depression im höheren Lebensalter nahmen nach Elektrokrampftherapie depressive und Angstsymptome in beiden Angstgruppen ab. Die globale Kognition blieb stabil.

Fragestellung

Ist die Ausgangsangst mit unterschiedlichen symptomatischen und kognitiven Verläufen nach Elektrokrampftherapie bei Depression im höheren Lebensalter verbunden?

Methode

Prospektive Self-controlled Pre-Post-Studie nach STROBE; 93 Patient:innen ≥60 Jahre mit akuter Elektrokrampftherapie. Vergleich mild-moderate vs. schwere Angst; Auswertung mit LMMs und hierarchischer Regression.

Ergebnisse

Beide Gruppen zeigten signifikante Rückgänge von Depressions- und Angstsymptomen. Schwere Angst: vergleichbare antidepressive Response (HAMD-24-Interaktion p=0,155), stärkere Verbesserungen in HAMA und einigen HAMD-Faktoren; MoCA und RBANS gesamt unverändert.

Schlussfolgerung der Autor:innen

Bei LLD sagt stärkere Ausgangsangst keine größere antidepressive Gesamtresponse auf ECT voraus, ist aber mit besseren Verbesserungen angstbezogener und psychomotorischer Symptomdimensionen verbunden. Die globale Kognition blieb unbeeinträchtigt.

Kernaussagen

  • Beide Angstgruppen verbesserten sich nach ECT bei Depression und Angst.
  • Schwere Ausgangsangst: kein größerer Gesamteffekt auf HAMD-24.
  • Globale Kognition blieb mit MoCA und RBANS stabil.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Alpha Psychiatry, online erschienen am 09.09.2026. Verfasst von Wenfeng Zhen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Beijing An…. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Science & Technology Commission.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Late-life depression (LLD) is commonly complicated by comorbid anxiety. However, whether the severity of baseline anxiety is associated with differential symptomatic and cognitive outcomes following electroconvulsive therapy (ECT) in LLD remains unclear, particularly with respect to cognitive safety in high-anxiety older patients.

Methods

This prospective self-controlled pre–post study was conducted in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. Ninety-three patients aged ≥60 years with LLD received an acute course of ECT and were stratified into mild-to-moderate anxiety (Hamilton Anxiety Rating Scale [HAMA] score 14–28) and severe anxiety (HAMA score ≥29) groups according to established HAMA severity cutoffs. Depressive symptoms (24-item Hamilton Depression Rating Scale [HAMD-24]), anxiety symptoms (HAMA-14), and cognitive performance (Montreal Cognitive Assessment [MoCA] and Repeatable Battery for the Assessment of Neuropsychological Status [RBANS]) were assessed at baseline and after completion of ECT treatment. Linear mixed-effects models (LMMs) with participant-level random intercepts were used to examine differential treatment trajectories while adjusting for demographic characteristics and baseline symptom severity. Hierarchical regression analyses were performed to determine whether improvement in anxiety symptoms (ΔHAMA) predicted antidepressant response (ΔHAMD) and cognitive change (ΔMoCA).

Results

Both groups demonstrated significant reductions in depressive and anxiety symptoms following ECT. Baseline HAMA and HAMD-24 scores were not significantly correlated (r = 0.12, p = 0.24), suggesting that anxiety and depressive symptom severity represented distinct constructs. After multivariable adjustment, the severe anxiety group showed an antidepressant response comparable to that of the mild-to-moderate anxiety group (HAMD-24 total score interaction, p = 0.155), but exhibited significantly greater improvements in HAMA total and subdomain scores (all p < 0.01), as well as in the HAMD anxiety/somatization and retardation factors (both p < 0.05). Global cognitive performance remained stable across groups, with no significant differences observed in MoCA or RBANS total scores (both p > 0.60). Improvement in the RBANS attention domain was the only cognitive outcome that differed significantly between groups, favoring the severe anxiety group (p = 0.004). Greater improvement in anxiety symptoms predicted a stronger antidepressant response (β = 0.31, p < 0.001); however, this association did not differ between anxiety severity groups (p = 0.316) and was not related to cognitive change (p = 0.443).

Conclusions

In patients with LLD, more severe baseline anxiety does not predict a greater overall antidepressant response to ECT but is associated with preferential improvement in anxiety-related and psychomotor symptom dimensions. ECT does not adversely affect global cognitive functioning regardless of baseline anxiety severity. These findings suggest that anxiety severity may help inform expectations regarding domain-specific symptomatic improvement and support the cognitive safety of ECT across the spectrum of anxiety severity in older adults. Clinical Trial Registration: This study is registered on the Chinese Clinical Trial Registry (ChiCTR) at https://www.chictr.org.cn/showproj.html?proj=205598 (registration number: ChiCTR2300078063).

Schlagwörter

Stichwörter der Autor:innen

anxietycognitive functionefficacyelectroconvulsive therapylate-life depression

Autor:innen und Institutionen

  • Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, 100088 Beijing, China.
  • Advanced Innovation Center for Human Brain Protection, Capital Medical University, 100088 Beijing, China.
  • Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30307, USA.
  • Mental Health Service Line, Joseph Maxwell Cleland Atlanta VA Medical Center, Decatur, GA 30033, USA.

ORCID-Profile: Yanping Ren, Xin Ma

Förderung

  • Beijing Municipal Science & Technology Commission

Zitieren

APA

Zhen, W., Wu, H., Lin, S., Zhu, D., Lian, S., Ren, L., Tang, Y., Ren, Y., & Ma, X. (2026). Changes in Symptoms and Cognition Following Electroconvulsive Therapy in Late-Life Depression: Analyses Stratified by Baseline Anxiety Levels. Alpha Psychiatry, 27(5). https://doi.org/10.31083/ap51154

Vancouver

Zhen W, Wu H, Lin S, Zhu D, Lian S, Ren L, et al. Changes in Symptoms and Cognition Following Electroconvulsive Therapy in Late-Life Depression: Analyses Stratified by Baseline Anxiety Levels. Alpha Psychiatry. 2026;27(5). doi:10.31083/ap51154

BibTeX
@article{Zhen2026,
  author = {Zhen, Wenfeng and Wu, Han and Lin, Shuo and Zhu, Dandi and Lian, Siyuan and Ren, Li and Tang, Yilang and Ren, Yanping and Ma, Xin},
  title = {Changes in Symptoms and Cognition Following Electroconvulsive Therapy in Late-Life Depression: Analyses Stratified by Baseline Anxiety Levels},
  journal = {Alpha Psychiatry},
  year = {2026},
  volume = {27},
  number = {5},
  doi = {10.31083/ap51154}
}
Kostenlos starten →